机构:[1]Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility, Jinan University, Guangzhou 510632, China[2]Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China[3]International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Jinan University, Guangzhou 510632, China[4]Institute of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830054, China[5]Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[6]College of Pharmacy, Guangzhou University of Chinese Medicine, Guangzhou 510405, China深圳市中医院深圳医学信息中心[7]Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, 100700 Beijing, China
This work was supported, in part, by National Key Research and Development
Program of China (2017YFC1700400, 2017YFC1700404, 2022YFC0867400), Natural
Science Foundation of China (82125038, 81904068, 81873209, U1801284, 81903821,
82174054), the Local Innovative and Research Teams Project of Guangdong Pearl
River Talents Program (2017BT01Y036), GDUPS (2019), Natural Science Foundation of
Guangdong (2019A1515010909, 2021A1515011297), Science and Technology
Program of Guangzhou (201903010062, 907158833068), and the Innovation Team
Project of Guangdong Provincial Department of Education (2020KCXTD003).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
最新[2025]版:
大类|1 区医学
小类|1 区生化与分子生物学1 区细胞生物学
第一作者:
第一作者机构:[1]Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility, Jinan University, Guangzhou 510632, China[2]Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China[3]International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Jinan University, Guangzhou 510632, China[4]Institute of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi 830054, China
通讯作者:
通讯机构:[1]Guangdong Engineering Research Center of Chinese Medicine & Disease Susceptibility, Jinan University, Guangzhou 510632, China[2]Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy, Jinan University, Guangzhou 510632, China[3]International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Jinan University, Guangzhou 510632, China
推荐引用方式(GB/T 7714):
Ma Xiao-Hui,Liu Jiang-Han-Zi,Liu Chun-Yu,et al.ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage[J].Signal transduction and targeted therapy.2022,7(1):288.doi:10.1038/s41392-022-01090-z.
APA:
Ma Xiao-Hui,Liu Jiang-Han-Zi,Liu Chun-Yu,Sun Wan-Yang,Duan Wen-Jun...&Shang Hongcai.(2022).ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage.Signal transduction and targeted therapy,7,(1)
MLA:
Ma Xiao-Hui,et al."ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage".Signal transduction and targeted therapy 7..1(2022):288